# Chinese Medicine for Patients With LCOVID-19 Symptoms

> **NCT04924881** · PHASE2 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 68 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** COVID Rehab Formula granules
- **OTHER:** Placebo granules

## Key facts

- **NCT ID:** NCT04924881
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04924881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04924881, "Chinese Medicine for Patients With LCOVID-19 Symptoms". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04924881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*